VR Logo

Acurx Pharmaceuticals Inc. (ACXP) download report


Healthcare | Biotechnology & Pharma Research

Acurx Pharmaceuticals Inc. (ACXP) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections.

IPO Date: 25-Jun-2021

Co-Founder & Exec. Chairman: Mr. Robert J. DeLuccia

Corp. Sec., Co-Founder, Pres, CEO & Director: Mr. David P. Luci CPA, CPA, Esq., J.D.

Listing: NASDAQ: ACXP

Country: United States

Headquarters: Staten Island, NY

Website: https://www.acurxpharma.com

Key Facts

Market cap: $37.26 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-13.94 Mln

Cash: $11.08 Mln

Total Debt: $0.00 Mln

Insider's Holding: 23.35%

Liquidity: Low

52 Week range: $2.33 - 6.35

Shares outstanding: 10,263,200

Stock Performance

Time Period Acurx Pharmaceuticals (ACXP) S&P BSE Sensex S&P Small-Cap 600
YTD-14.26-9.18-18.78
1 month41.79-4.78-8.00
3 months12.96-9.66-13.65
1 Year-41.930.81-17.19
3 Years--10.336.10
5 Years--11.345.87
10 Years--11.749.84
As on 01-Jul-2022